ASPACAM calls for faster diagnosis of amyloidosis and stronger multidisciplinary care
Published
The Amyloidosis Patients' Association (ASPACAM) has denounced the delays that many people face in being diagnosed with amyloidosis. This rare disease occurs when abnormal proteins build up in organs and damage them.
According to the association, delayed diagnosis can greatly affect patients' health, because symptoms are often varied and are confused with those of other diseases. For this reason, ASPACAM considers it necessary for doctors from different specialties to work in a coordinated way to detect the disease in time.
In addition, the organisation calls for more research into amyloidosis and more support for patients and their families. For ASPACAM, improving access to information and healthcare resources is essential so that those affected can have a better quality of life.
In short, ASPACAM urges authorities and health professionals to move forward on early diagnosis and multidisciplinary care for this disease. The association insists that rapid detection and coordinated treatment are key for patients in Spain.
Sources: Demócrata
More Spain news
- Warning about unlicensed online casinos in Spain: what risks they pose
- Ten years of the Victims of Crime Statute: the University of Valencia organises a conference to analyse its impact
- Making Science receives a €2.5 million loan to boost its international growth
- Making Science receives a €2.5 million loan to boost artificial intelligence
- Rayo Vallecano and Athletic Club face off in La Liga: live coverage and statistics
- Atlético de Madrid could sign Martín Zubimendi in January
- Spain wins four silvers and three bronzes at the Clio Sports
- Cucurella highlights Arda Güler as the Real Madrid player who goes most unnoticed